Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Validate Patient-Reported Outcome Instruments in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC)
Conditions
Interventions
ALIS
Azithromycin
+2 more
Locations
62
United States
USA008
Birmingham, Alabama, United States
USA062
Fresno, California, United States
USA048
San Diego, California, United States
USA050
Stanford, California, United States
USA023
Washington D.C., District of Columbia, United States
USA003
Clearwater, Florida, United States
Start Date
December 22, 2020
Primary Completion Date
May 9, 2023
Completion Date
May 9, 2023
Last Updated
June 28, 2024
NCT07094711
NCT03421743
NCT04154826
NCT02340897
Lead Sponsor
Insmed Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions